Roivant Sciences (ROIV) Debt to Equity (2021 - 2024)
Roivant Sciences (ROIV) reported Debt to Equity of $0.03 for Q2 2024, down 42.32% on a YoY basis from $0.06 in Q3 2023, and up 349.9% quarter-over-quarter from $0.01 in Q1 2024.
Roivant Sciences (ROIV) Debt to Equity (2021 - 2024) Analysis & Trends
Roivant Sciences has reported Debt to Equity for 4 years, with the latest figure at $0.03 in Q2 2024.
- For the quarter ending Q2 2024, Debt to Equity fell 42.32% year-over-year to $0.03; the trailing twelve-month figure through Jun 2024 stood at $0.03 (down 42.32% YoY), and the FY2024 full-year result was $0.01, down 93.85% from the prior year.
- Debt to Equity for Q2 2024 stood at $0.03, up from $0.01 in the prior quarter.
- The five-year high for Debt to Equity was $0.16 in Q3 2023, with the low at $0.01 in Q1 2024.
- Historically, Debt to Equity has averaged $0.06 across 4 years, with a median of $0.06 in 2023.
- Annual changes were most pronounced in 2023 — Debt to Equity surged 680.26% — and 2024, when it plunged 93.85%.
- Roivant Sciences' Debt to Equity stood at $0.09 in 2021, then plunged by 44.46% to $0.05 in 2022, then tumbled by 34.44% to $0.03 in 2023, then increased by 4.42% to $0.03 in 2024.
- The last three Debt to Equity figures came in at $0.03 (Q2 2024), $0.01 (Q1 2024), and $0.03 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.08 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.08 |